Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)Recruiting
NCT06103864Phase 3Updated Aug 20, 2026
Sponsor: AstraZeneca
Breast Cancer
United States, Argentina, Australia, Brazil, Canada +19 more
Resistance Training to Prevent Muscle Loss During Treatment With TirzepatideNot Yet Recruiting
NCT07777575Phase 4Updated Aug 20, 2026
Sponsor: Technical University of Munich
Obesity (BMI>30)
Germany
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation TherapyRecruiting
NCT05976685NAUpdated Aug 20, 2026
Sponsor: Insel Gruppe AG, University Hospital Bern
Ischemic Stroke · Atrial Fibrillation
Belgium, Germany, New Zealand, Spain, Switzerland +1 more
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseActive Not Recruiting
NCT06926660Phase 2Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Chronic Kidney Disease
United States, Argentina, Australia, Belgium, Brazil +19 more
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseRecruiting
NCT07064473Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Diabetes Mellitus, Type 2 · Hypertension · Cardiovascular Diseases
United States, Argentina, Australia, Austria, Belgium +46 more
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusRecruiting
NCT07430306Phase 3Updated Aug 20, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Canada, France, Germany, Italy +4 more
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)Recruiting
NCT07107945Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Chronic Kidney Disease
United States, Argentina, Australia, Belgium, Canada +13 more
Long-Term Follow-up of Subjects Who Were Treated With ST-920Active Not Recruiting
NCT05039866N/AUpdated Aug 20, 2026
Sponsor: Sangamo Therapeutics
Fabry Disease · Fabry Disease, Cardiac Variant
United States, Australia, Canada, Germany, United Kingdom
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
NCT04033445Phase 2, Phase 3Updated Aug 20, 2026
Sponsor: Janssen Research & Development, LLC
Ulcerative Colitis
United States, Argentina, Australia, Austria, Belgium +29 more
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.Recruiting
NCT06382948Phase 3Updated Aug 20, 2026
Sponsor: MedSIR
Advanced Breast Cancer · ER-positive Breast Cancer · HER2-negative Breast Cancer · ESR1 Gene Mutation
Austria, Brazil, Czechia, France, Germany +4 more
Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global RegistryActive Not Recruiting
NCT04907240N/AUpdated Aug 20, 2026
Sponsor: W.L.Gore & Associates
Peripheral Artery Disease · Popliteal Aneurysm · Hemodialysis Access · Visceral Artery Aneurysms
Belgium, France, Germany, Greece, Italy +4 more
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative ColitisRecruiting
NCT07665723Phase 1Updated Aug 20, 2026
Sponsor: Hoffmann-La Roche
Active Ulcerative Colitis
United States, Belgium, Germany, Poland, United Kingdom
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard TreatmentActive Not Recruiting
NCT06151574Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Lung Cancer, Non-squamous, Non-small Cell
United States, Argentina, Australia, Austria, Belgium +21 more
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia GravisCompleted
NCT03971422Phase 3Updated Aug 20, 2026
Sponsor: UCB Biopharma SRL
Generalized Myasthenia Gravis
United States, Belgium, Canada, Czechia, Denmark +12 more
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaRecruiting
NCT06091865Phase 3Updated Aug 20, 2026
Sponsor: Regeneron Pharmaceuticals
Diffuse Large B-cell Lymphoma (DLBCL)
United States, Australia, Austria, Belgium, Brazil +16 more
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced CoagulopathyRecruiting
NCT06854640Phase 1Updated Aug 20, 2026
Sponsor: Bayer
Sepsis · Coagulopathy
Belgium, France, Germany, Netherlands
A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved IndicationRecruiting
NCT07612267Phase 4Updated Aug 20, 2026
Sponsor: Eli Lilly and Company
Lactation · Inflammatory Bowel Disease
United States, Canada, Denmark, Germany, Israel +2 more
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic DysfunctionTerminated
NCT01065454Phase 2Updated Aug 20, 2026
Sponsor: Bayer
Hypertension, Pulmonary · Ventricular Dysfunction, Left
United States, Australia, Austria, Belgium, Canada +13 more
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With NerandomilastRecruiting
NCT06238622Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis · Progressive Pulmonary Fibrosis
United States, Argentina, Australia, Austria, Belgium +39 more
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex AblationRecruiting
NCT07777744N/AUpdated Aug 20, 2026
Sponsor: University Hospital, Basel, Switzerland
Ventricular Tachycardia (VT) · Premature Ventricular Complexes
United States, Austria, Canada, China, Croatia +11 more
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)Completed
NCT05915728Phase 3Updated Aug 20, 2026
Sponsor: Bayer
Contrast Enhancement in Magnetic Resonance Imaging · Non-central Nervous System Pathology
United States, Argentina, Bulgaria, Canada, China +11 more
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationRecruiting
NCT07441642Phase 2Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Geographic Atrophy Secondary to Age-related Macular Degeneration
United States, Australia, Bulgaria, Canada, Czechia +10 more
Tezspire Cardiac Events PASSRecruiting
NCT06951867N/AUpdated Aug 20, 2026
Sponsor: AstraZeneca
Cardiovascular Events · MACE
United States, Denmark, France, Germany
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)Recruiting
NCT07409181Phase 2Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Systemic Lupus Erythematosus
United States, Argentina, Australia, Brazil, Bulgaria +16 more
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease ProgressionNot Yet Recruiting
NCT07540988Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Interstitial Lung Diseases
United States, Argentina, Austria, Belgium, Brazil +14 more

Previous page Next page